<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Inactivation of RUNX3/p46 Promotes Cutaneous T-Cell Lymphoma</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Ahmed</forename><surname>Haider</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Dermatology</orgName>
								<orgName type="institution">Charite ´e Universitaetsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Anne</forename><surname>Steininger</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Max Planck Institute for Molecular Genetics</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Reinhard</forename><surname>Ullmann</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Max Planck Institute for Molecular Genetics</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Institut fu ¨r Radiobiologie der Bundeswehr in Verbindung mit</orgName>
								<orgName type="institution">Universita ¨t Ulm</orgName>
								<address>
									<settlement>Munich</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Michael</forename><surname>Hummel</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Institute of Pathology</orgName>
								<orgName type="institution">Charite ´e Universitaetsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Lora</forename><surname>Dimitrova</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Institute of Pathology</orgName>
								<orgName type="institution">Charite ´e Universitaetsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Marc</forename><surname>Beyer</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Dermatology</orgName>
								<orgName type="institution">Charite ´e Universitaetsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Staffan</forename><surname>Vandersee</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Dermatology</orgName>
								<orgName type="institution">Charite ´e Universitaetsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="department" key="dep1">Central German Armed Forces hospital</orgName>
								<orgName type="department" key="dep2">Department of Dermatology and Allergy</orgName>
								<address>
									<settlement>Koblenz</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Dido</forename><surname>Lenze</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Institute of Pathology</orgName>
								<orgName type="institution">Charite ´e Universitaetsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Wolfram</forename><surname>Sterry</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Dermatology</orgName>
								<orgName type="institution">Charite ´e Universitaetsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Chalid</forename><surname>Assaf</surname></persName>
							<email>chalid.assaf@charite.de</email>
							<affiliation key="aff0">
								<orgName type="department">Department of Dermatology</orgName>
								<orgName type="institution">Charite ´e Universitaetsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="department">Department of Dermatology</orgName>
								<orgName type="institution">HELIOS Klinikum Krefeld</orgName>
								<address>
									<settlement>Krefeld</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Markus</forename><surname>Mo ¨bs</surname></persName>
							<email>markus.moebs@charite.de</email>
							<affiliation key="aff0">
								<orgName type="department">Department of Dermatology</orgName>
								<orgName type="institution">Charite ´e Universitaetsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">Institute of Pathology</orgName>
								<orgName type="institution">Charite ´e Universitaetsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Markus</forename><surname>Mo</surname></persName>
						</author>
						<author>
							<affiliation key="aff6">
								<orgName type="department">Institute of Pathology</orgName>
								<orgName type="institution">Charite ´e Universitaetsmedizin Berlin</orgName>
								<address>
									<addrLine>Charite ´platz 1</addrLine>
									<postCode>10117</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff7">
								<orgName type="department" key="dep1">or Chalid Assaf</orgName>
								<orgName type="department" key="dep2">Department of Dermatology</orgName>
								<orgName type="institution">Charite ´e Universitaetsmedizin Berlin</orgName>
								<address>
									<addrLine>Charite ´platz 1</addrLine>
									<postCode>10117</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Inactivation of RUNX3/p46 Promotes Cutaneous T-Cell Lymphoma</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">FFC32D4F4D659B8219AEDECAD0FE3642</idno>
					<idno type="DOI">10.1016/j.jid.2016.05.126</idno>
					<note type="submission">Received 2 November 2015; revised 30 May 2016; accepted 31 May 2016; accepted manuscript published online 1 July 2016; corrected proof published online 17 August 2016</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:51+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>CTCL, cutaneous T-cell lymphoma</term>
					<term>PBMC, peripheral blood mononuclear cell</term>
					<term>SNP, single-nucleotide polymorphism</term>
					<term>SS, Se ´zary syndrome</term>
					<term>Th, T helper</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>The key role of RUNX3 in physiological T-cell differentiation has been extensively documented.</s><s>However, information on its relevance for the development of human T-cell lymphomas or leukemias is scarce.</s><s>Here, we show that alterations of RUNX3 by either heterozygous deletion or methylation of its distal promoter can be observed in the tumor cells of 15 of 21 (71%) patients suffering from Se ´zary syndrome, an aggressive variant of cutaneous T-cell lymphoma.</s><s>As a consequence, mRNA levels of RUNX3/p46, the isoform controlled by the distal promoter, are significantly lower in Se ´zary syndrome tumor cells.</s><s>Re-expression of RUNX3/p46 reduces cell viability and promotes apoptosis in a RUNX3/p46 low cell line of cutaneous T-cell lymphoma.</s></p><p><s>Based on this, we present evidence that RUNX3 can act as a tumor suppressor in a human T-cell malignancy and suggest that this effect is predominantly mediated through transcripts from its distal promoter, in particular RUNX3/p46.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>INTRODUCTION</head><p><s>RUNX3 belongs to a family of highly conserved transcription factors and is one of the key gene expression regulators in several development processes including hematopoiesis <ref type="bibr" target="#b1">(Bangsow et al., 2001)</ref>.</s><s>RUNX3 expression is regulated by two different promoters, a distal and a proximal promoter, leading to at least two different RUNX3 proteins with DNA binding capacity <ref type="bibr" target="#b53">(Puig-Kroger et al., 2010)</ref> (Figure <ref type="figure" target="#fig_0">1</ref>).</s><s>The RUNX3 isoform, which is derived from the distal promoter (RUNX3/p46), has 19 unique amino acids at its N-terminal end that are not present in the protein derived from the proximal promoter (RUNX3/p44).</s><s>The sequence specific to the distal RUNX3 promoter transcript is highly conserved in human, mouse, and rat and comprises an independent transcriptional activation domain <ref type="bibr" target="#b11">(Chung et al., 2007)</ref>.</s><s>RUNX3 plays a pivotal role in T-cell development, because it is required for the appropriate expression of CD4 or CD8 and also for T helper (Th) 1/Th2 differentiation <ref type="bibr" target="#b14">(Djuretic et al., 2007;</ref><ref type="bibr" target="#b48">Naoe et al., 2007;</ref><ref type="bibr" target="#b55">Schulz et al., 2009;</ref><ref type="bibr" target="#b58">Taniuchi et al., 2002;</ref><ref type="bibr" target="#b65">Wang et al., 2012;</ref><ref type="bibr">Yarmus et al., 2006)</ref>.</s><s>Moreover, recent reports could link RUNX3 to the development of several T-cellemediated inflammatory diseases <ref type="bibr" target="#b0">(Apel et al., 2013;</ref><ref type="bibr" target="#b21">Evans et al., 2011;</ref><ref type="bibr" target="#b31">Jeffries et al., 2011;</ref><ref type="bibr" target="#b45">Lian et al., 2013;</ref><ref type="bibr" target="#b59">Tsoi et al., 2012)</ref>.</s></p><p><s>In cancer, RUNX3 is frequently inactivated in solid tumors and its loss has an impact on apoptosis resistance and cell proliferation <ref type="bibr" target="#b8">(Chi et al., 2005;</ref><ref type="bibr" target="#b29">Ito et al., 2008;</ref><ref type="bibr">Li et al., 2002;</ref><ref type="bibr" target="#b66">Whittle et al., 2015;</ref><ref type="bibr" target="#b68">Yano et al., 2006)</ref>, senescence <ref type="bibr" target="#b38">(Kilbey et al., 2008)</ref>, and DNA repair <ref type="bibr" target="#b7">(Chen et al., 2008;</ref><ref type="bibr" target="#b57">Tanaka et al., 2007)</ref>, as well as cell adhesion or formation of metastasis and angiogenesis <ref type="bibr" target="#b6">(Chen et al., 2013;</ref><ref type="bibr" target="#b24">Grueter et al., 2005;</ref><ref type="bibr" target="#b51">Peng et al., 2006;</ref><ref type="bibr" target="#b54">Sakakura et al., 2005)</ref>.</s><s>Moreover, it is postulated to function as a tumor suppressor whose inactivation plays a major role in, for example, gastric cancer <ref type="bibr">(Li et al., 2002)</ref> and, as recently shown, in pancreatic ductal adenocarcinoma <ref type="bibr" target="#b66">(Whittle et al., 2015)</ref>.</s><s>However, despite its postulated function as a tumor suppressor in many solid tumors and its pivotal role for T-cell development and differentiation, not much is known about its relevance for human hematologic malignancies.</s></p><p><s>Cutaneous T-cell lymphomas (CTCLs) are most often characterized by the proliferation of malignant CD4 þ T-helper memory cells displaying a Th2 phenotype in advanced stages <ref type="bibr" target="#b67">(Willemze et al., 2005)</ref>.</s><s>The transcription factor RUNX3 could be of interest regarding CTCL biology for several reasons.</s><s>First, RUNX3 most probably exerts its tumor suppressor function by regulating transforming growth factor-b signaling <ref type="bibr" target="#b10">(Chuang and Ito, 2010;</ref><ref type="bibr" target="#b30">Ito and Miyazono, 2003)</ref>.</s><s>Defective or deregulated transforming growth factor-b signaling has already been shown for CTCL <ref type="bibr" target="#b5">(Capocasale et al., 1995;</ref><ref type="bibr">Kadin et al., 2001;</ref><ref type="bibr" target="#b42">Lee et al., 2012;</ref><ref type="bibr" target="#b61">van Doorn et al., 2004)</ref>.</s><s>Second, RUNX3, and in particular RUNX3/p46, is crucial for the differentiation of naive CD4 þ T cells into Th1 cells but not into Th2 <ref type="bibr" target="#b14">(Djuretic et al., 2007;</ref><ref type="bibr" target="#b39">Kohu et al., 2009;</ref><ref type="bibr" target="#b48">Naoe et al., 2007;</ref><ref type="bibr" target="#b55">Schulz et al., 2009;</ref><ref type="bibr" target="#b65">Wang et al., 2012)</ref>.</s><s>Therefore, loss of function of RUNX3/p46 could lead to a predominance of Th2 cytokines, which is the case in tumor cells of CTCL <ref type="bibr" target="#b17">(Dummer et al., 2001;</ref><ref type="bibr" target="#b25">Guenova et al., 2013;</ref><ref type="bibr" target="#b41">Lee et al., 1999;</ref><ref type="bibr" target="#b63">Vowels et al., 1992)</ref>.</s></p><p><s>Here, we present an integrative analysis of genomic aberrations, promoter methylation, and gene expression of RUNX3 in primary tumor cells of patients with Se ´zary syndrome (SS).</s><s>Our results link RUNX3-in particular the long isoform of RUNX3 (RUNX3/p46)-to a human T-cell malignancy.</s><s>Moreover, we show that ectopic expression of RUNX3/p46 in a CTCL cell line with very low levels of endogenous RUNX3/p46 diminishes cell viability by inducing apoptosis.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RESULTS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Genomic loss of RUNX3 is a frequent event in SS</head><p><s>We recently analyzed enriched primary tumor cells from 20 SS patients by array comparative genomic hybridization (aCGH) <ref type="bibr" target="#b56">(Steininger et al., 2011)</ref>.</s><s>We supplemented this data set with the analysis of three additional primary tumor cell samples and re-evaluated the combined data set with a focus on the chromosomal region 1p36.</s><s>In doing so, we identified a region of frequent heterozygous genomic loss ranging from chromosome 1: <ref type="bibr">25,065,561e25,241,048 (hg18)</ref>.</s><s>This interval was found deleted in 9 of 23 SS patient samples (39%) and the SS-derived cell line SeAx and encompasses only a single gene, which codes for the transcription factor RUNX3 (Figure <ref type="figure" target="#fig_1">2a</ref>, Table <ref type="table" target="#tab_0">1</ref>).</s><s>Fluorescence in situ hybridization on peripheral blood mononuclear cells (PBMCs) from five of these nine patients, the two SS cell lines SeAx and Hut-78, and two other CTCL cell lines, MyLa (mycosis fungoides) and HH (aggressive CTCL not otherwise specified), confirmed our aCGH results and indicated that the deletions are of somatic origin in all cases tested (Figure <ref type="figure" target="#fig_1">2b</ref>, Table <ref type="table" target="#tab_0">1</ref>).</s></p><p><s>Point mutations within RUNX3 are absent in SS Next, we sequenced the coding region of RUNX3, including exon/intron borders, in 25 tumor cell samples and the two SSderived cell lines, SeAx and Hut-78, but we did not find any obvious deleterious mutations.</s><s>However, in 9 of 25 (36%) tumor cell samples and both SS cell lines we detected a nonsynonymous single-nucleotide variant that corresponds to an inherited single-nucleotide polymorphism (SNP) (rs6672420), which leads to an amino acid exchange at position 18 of RUNX3/p46 from isoleucine to asparagine (Table <ref type="table" target="#tab_0">1</ref>).</s><s>A synonymous SNP (rs143410594) was found in one patient.</s><s>All variants were found in patient samples that did not show heterozygous deletion of RUNX3.</s><s>Sequencing of RUNX3 in isolated monocytes from six of those nine patients showed that all polymorphisms were of germ line origin (Table <ref type="table" target="#tab_0">1</ref>).</s></p><p><s>Methylation of the distal, but not the proximal, promoter is a specific feature of SS cells Because the proximal RUNX3 promoter is frequently methylated in various solid tumors, we first analyzed its methylation status by bisulfite sequencing in 19 tumor cell samples, CD4 þ T cells of 10 healthy volunteers, the four CTCL cell lines, and five T-cell acute lymphoblastic leukemia cell lines (Jurkat, Molt-4, KE-37, CCRF, and K45).</s><s>We did not find promoter methylation in any of the samples (data not shown).</s><s>We then proceeded to analyze the distal RUNX3 promoter, including five additional SS samples.</s><s>Although all samples from healthy volunteers and all T-cell acute lymphoblastic leukemia cell lines did not show any promoter methylation, in 6 of 24 SS samples, the analyzed CpG sites were mainly or completely methylated (&gt;70% methylation of analyzed CpG sites), and 5 of 24 samples showed a mixed methylation pattern, resulting in an overall methylation frequency of 46% in the analyzed patient samples (Table <ref type="table" target="#tab_0">1 and Figure</ref>  <ref type="figure" target="#fig_1">2c</ref>).</s><s>Of the four tested CTCL cell lines, we detected methylation of the distal promoter in MyLa cells, in which the analyzed CpG sites were mainly methylated.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cytoplasmic retention of RUNX3 protein is not observed in CTCL</head><p><s>To test if cytoplasmic retention of the protein might be another mechanism of RUNX3 inactivation in SS or other entities of CTCL, we stained RUNX3 in our set of CTCL cell lines and Jurkat cells by immunofluorescence staining.</s><s>Although all of the five cell lines stained positive for RUNX3 with different intensities, none of them showed an obvious cytoplasmic retention of the protein that could be verified by Western blot analysis of nuclear and cytoplasmic protein extracts (Figure <ref type="figure" target="#fig_1">2d and e</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RUNX3/p46 expression is reduced in SS tumor cells</head><p><s>We next tried to determine whether our genomic findings are reflected by a reduced RUNX3 expression in SS tumor cells.</s><s>Immunohistochemical staining of RUNX3 in 10 skin biopsy samples from SS patients-four with and six without genomic loss of RUNX3-did not show reduced RUNX3 protein levels within the tumor cells of any sample (data not shown).</s><s>However, there is no commercially available antibody that can distinguish between the different RUNX3 isoforms.</s></p><p><s>To assess expression values of the different transcripts originating from the two RUNX3 promoters, a quantitative real-time reverse transcriptaseePCR was then performed.</s><s>The first gene expression assay specifically detects the transcript of RUNX3/p46 transcribed from the distal promoter, the second assay detects transcript from both, the distal and the proximal RUNX3 promoter.</s><s>When comparing the relative expression values between CD4 þ -enriched blood circulating tumor cells from SS patients to CD4 þ memory T cells from healthy control subjects, RUNX3/p46 expression was significantly lower in the tumor cells than in our control samples (P 0.001, Figure <ref type="figure" target="#fig_4">3a and c</ref>).</s><s>However, because of the low number of investigated cases (11/21), a direct correlation of RUNX3/p46 expression to the genetic alteration of RUNX3 (e.g., loss, methylation, or SNP) was not possible.</s><s>For total RUNX3 expression (RUNX3/p44 and RUNX3/p46), no significant difference could be detected (Figure <ref type="figure" target="#fig_4">3b and c</ref>).</s></p><p><s>To verify whether our findings in primary tumor cells can be replicated in CTCL cell lines, we also checked for expression of the different RUNX3 transcripts in SeAx, Hut78, HH, and MyLa cells.</s><s>Although overall expression of RUNX3 was higher in CTCL cell lines than Jurkat cells, the transcript coding for RUNX3/p46 was particularly low in MyLa and HH cells (Figure <ref type="figure" target="#fig_4">3d</ref>).</s><s>This makes these cell lines a valuable model to study the RUNX3/p46 function in CTCL cells by means of ectopic expression of this protein.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Ectopic expression of RUNX3/p46 impairs cell viability and induces apoptosis</head><p><s>Because loss of RUNX3 has been linked to impaired apoptosis and cell cycle control in solid tumors <ref type="bibr" target="#b8">(Chi et al., 2005;</ref><ref type="bibr" target="#b29">Ito et al., 2008;</ref><ref type="bibr">Li et al., 2002;</ref><ref type="bibr" target="#b68">Yano et al., 2006)</ref>, we checked if re-expression of RUNX3/p46 can induce apoptosis or alter proliferation in a CTCL cell line model.</s><s>To this end, we selected MyLa cells, because MyLa is the only cell line tested that shows both very low expression of RUNX3/p46 and methylation of the distal RUNX3 promoter.</s><s>Forty-eight hours after transfection with a p46 expression construct we monitored for trypan blue-positive cells and assessed the fractions of apoptotic and proliferating cells.</s><s>In addition, we cultured equal numbers of trypan blue-negative cells transfected either with RUNX3/p46 or the empty vector control (MOCK) for another 24 hours and then determined the proportion of viable cells by using a WST-1 assay.</s><s>Transfection with the RUNX3/p46 expression construct resulted in a significantly higher proportion of trypan blue-positive cells when compared with MOCK-transfected controls (P 0.01) (Figure <ref type="figure" target="#fig_5">4a</ref>).</s><s>This finding is in line with the results obtained by determining the amount of highmolecular-weight genomic DNA of ethanol fixed/ permeabilized cells with propidium iodide, which indicated an elevated number of apoptotic cells (sub-G1 fraction) after transfection with the RUNX3/p46 expression construct (P 0.05, Figure <ref type="figure" target="#fig_5">4b and c</ref>).</s><s>An alteration of the proportion of proliferating cells (S plus G2/M phase), however, was not observed (Figure <ref type="figure" target="#fig_5">4c</ref>).</s><s>That the decrease of cell viability was indeed related to apoptosis induction was confirmed by Western blot analysis of cleaved caspase-3, which showed an increased processing of caspase-3 toward the highly active p17 fragment in RUNX3/p46 transfected cells (Figure <ref type="figure" target="#fig_5">4d</ref>).</s><s>Compared with MOCK-transfected cells, the trypan bluenegative cell fraction of RUNX3/p46 transfected cells also showed a reduced number of viable cells when cultured for an additional 24 hours (P 0.05) (Figure <ref type="figure" target="#fig_5">4e</ref>).</s><s>Heterogeneous genotype with two to four copies of centromere 1 and three to six copies of RUNX3.</s></p><p><s>A Haider et al.</s></p><p><s>Loss of RUNX3/p46 in Human T-Cell Lymphoma</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DISCUSSION</head><p><s>Recurrent genomic deletions at chromosome band 1p36.11</s><s>have already been described in SS, and recent publications have also focused on potential disease-relevant genes in this region <ref type="bibr" target="#b9">(Choi et al., 2015;</ref><ref type="bibr" target="#b12">da Silva Almeida et al., 2015;</ref><ref type="bibr" target="#b37">Kiel et al., 2015;</ref><ref type="bibr" target="#b64">Wang et al., 2015)</ref>.</s><s>In these studies, deletion of RUNX3 had been detected in up to 45% of leukemic CTCLs, including SS.</s><s>However, because of slightly different minimal common regions and a different approach to identifying candidate genes by combining copy number variation analysis with the detection of deleterious point mutations, RUNX3 did not come into the focus of the investigators.</s><s>In contrast, by integrative analysis of genomic deletions and promoter methylation, we identified RUNX3 alterations in 71% of the patients with both data sets available.</s><s>These frequent changes translate into a significant down-regulation of RNA transcripts coding for the long isoform (RUNX3/p46) in blood circulating tumor cells, making RUNX3/p46 a promising tumor suppressor candidate in this human T-cell lymphoma.</s></p><p><s>In general, information regarding the role of RUNX3 in the pathogenesis of human T-cell malignancies is scarce.</s><s>Recently, RUNX3 promoter hypermethylation in patients with acute myeloid leukemia and leukemia cell lines were described <ref type="bibr" target="#b20">(Estecio et al., 2015)</ref>.</s><s>However, our differential promoter analyses show that methylation does not affect the proximal CpG promoter but the distal non-CpG promoter that controls the transcription of the long isoform RUNX3/p46 <ref type="bibr" target="#b26">(Han et al., 2011)</ref>.</s><s>This may be one reason why the impact of RUNX3 promoter methylation on the emergence of hematological disorders has escaped attention until now.</s><s>Deleterious somatic point mutations of RUNX3 were absent in the CTCL samples, which is in line with previous findings in CTCL and acute myeloid leukemia <ref type="bibr" target="#b9">(Choi et al., 2015;</ref><ref type="bibr" target="#b37">Kiel et al., 2015;</ref><ref type="bibr" target="#b49">Otto et al., 2003)</ref> and applies to several other tumor suppressor genes in CTCL, including E2A or TNFAIP3 <ref type="bibr" target="#b3">(Braun et al., 2011;</ref><ref type="bibr" target="#b9">Choi et al., 2015;</ref><ref type="bibr" target="#b13">Dereure et al., 2002;</ref><ref type="bibr" target="#b36">Kapur et al., 2001;</ref><ref type="bibr" target="#b37">Kiel et al., 2015;</ref><ref type="bibr" target="#b40">Lamprecht et al., 2012;</ref><ref type="bibr" target="#b56">Steininger et al., 2011)</ref>, thereby underscoring the importance of alternative mechanisms of gene inactivation in CTCL <ref type="bibr" target="#b9">(Choi et al., 2015;</ref><ref type="bibr" target="#b37">Kiel et al., 2015;</ref><ref type="bibr" target="#b62">van Doorn et al., 2005)</ref>.</s><s>Although we did not find any tumor-specific somatic point mutation in RUNX3, we detected one intragenic germ line variant (rs6672420) in 9 of 25 SS patients.</s><s>The allelic frequency of this SNP in European individuals is 49% <ref type="bibr" target="#b22">(Flicek et al., 2014)</ref>, approximately matching the frequency observed in our patients with balanced copy number status of RUNX3 (43%).</s><s>However, within the subgroup of patients with heterozygous deletions (n ¼ 8), no single patient carried this variation.</s><s>Interestingly, rs6672420 has already been associated with increased susceptibility to intestinal-type gastric cancer <ref type="bibr" target="#b46">(Lim et al., 2011)</ref>.</s><s>Functionally, this SNP has been reported to up-regulate the expression of a transcriptionally inactive RUNX3 isoform potentially competing with RUNX3/p46 <ref type="bibr" target="#b46">(Lim et al., 2011;</ref><ref type="bibr" target="#b53">Puig-Kroger et al., 2010)</ref>.</s><s>The exact relevance of this SNP for CTCL pathogenesis remains elusive.</s></p><p><s>Cytoplasmic retention is another mechanism used by tumor cells to decrease nuclear RUNX3 levels <ref type="bibr" target="#b10">(Chuang and Ito, 2010)</ref>, but neither Western blot analysis nor immunofluorescence staining provided evidence for protein mislocalization in CTCL cell lines.</s><s>However, we cannot exclude the possibility that retention of RUNX3/p46 was masked by the nuclear localization of the much more strongly expressed RUNX3/p44, because the antibody is not able to discriminate between both isoforms.</s></p><p><s>Mechanistically, we provide strong evidence that loss of RUNX3/p46 effects cell survival and propagation of a CTCL tumor cell line.</s><s>Ectopic expression of RUNX3/p46 in MyLa cells led to a significant decrease in cell viability, most probably because of the observed induction of apoptosis.</s><s>This is in line with findings in solid tumors, where loss of RUNX3 expression is also associated with apoptosis resistance and increased cell proliferation <ref type="bibr" target="#b8">(Chi et al., 2005;</ref><ref type="bibr" target="#b29">Ito et al., 2008;</ref><ref type="bibr">Li et al., 2002;</ref><ref type="bibr" target="#b68">Yano et al., 2006)</ref>.</s><s>Knowing that MyLa is derived from a patient with mycosis fungoides <ref type="bibr" target="#b35">(Kaltoft et al., 1992)</ref>, we chose it as a cell line model because it originates from mature T cells, its distal RUNX3 promoter is hypermethylated, and it has low RUNX3/p46 expression, resembling the features of our SS samples.</s></p><p><s>So far, RUNX3/p46 has not been investigated in the context of enacting possible tumor suppressor activity of RUNX3.</s><s>However, in T cells there is evidence that isoforms of RUNX3, expressed from the distal promoter, are of particular interest when studying RUNX3 function.</s><s>First, lineage choice between Th and T-effector cells is mainly regulated by isoforms expressed from the distal promoter <ref type="bibr" target="#b4">(Cao et al., 2010;</ref><ref type="bibr" target="#b18">Egawa and Littman, 2008;</ref><ref type="bibr" target="#b50">Park et al., 2010)</ref>.</s><s>Second, the promotion of lymphomagenesis by proviral integration at the Dsi1 locus results in up-regulation of transcription, particularly from this promoter.</s><s>Finally, T lymphocytes are the only cells studied so far in which the distal promoter is not silenced by methylation <ref type="bibr" target="#b26">(Han et al., 2011)</ref>.</s><s>To what extent this nonredundant function of RUNX3/p46 is solely mediated by its additional transcriptional activation domain <ref type="bibr" target="#b11">(Chung et al., 2007)</ref> has still to be elucidated.</s></p><p><s>This finding is in line with our results in SS: we did not observe promoter methylation or significant changes in gene expression when addressing the proximal promoter or its transcript, in contrast to the significant differences when focusing on the distal promoter and the transcript coding for RUNX3/p46.</s><s>The use of antibodies or gene expression assays that do not discriminate the different RUNX3 isoforms are, therefore, not appropriate for comparing RUNX3 gene expression in tumor cells and control samples, particularly in T-cell malignancies.</s></p><p><s>Down-regulation of RUNX3 in CTCL was recently also reported by <ref type="bibr">Dulmage et al. (2015)</ref>.</s><s>They could show that the transcription factor thymocyte selection-associated highmobility group box protein (TOX), which is overexpressed in CTCL <ref type="bibr" target="#b2">(Boonk et al. 2015;</ref><ref type="bibr" target="#b27">Huang et al., 2014</ref><ref type="bibr" target="#b28">Huang et al., , 2015;;</ref><ref type="bibr" target="#b71">Zhang et al., 2012)</ref>, indirectly suppresses RUNX3, therefore acting as a negative regulator of RUNX3 expression.</s><s>Although only global RUNX3 was analyzed, this study <ref type="bibr">(Dulmage et al., 2015)</ref> shows an additional mechanism leading to downregulation of RUNX3 besides the demonstrated genomic deletions and distal promoter methylation, emphasizing its importance in the pathogenesis of CTCL.</s></p><p><s>In conclusion, our data highlight that RUNX3/p46 is frequently inactivated in SS by genomic deletions and methylation of the distal RUNX3 promoter.</s><s>Ectopic expression of RUNX3/p46 reduces viability and induces apoptosis, thereby providing direct evidence that RUNX3 can act as a tumor suppressor in a human T-cell malignancy.</s><s>In addition, our results show that transcripts from the different RUNX3 promoters have to be taken into account when analyzing the tumor suppressor function of RUNX3, at least in T-cell malignancies.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>MATERIALS AND METHODS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Patient samples</head><p><s>Peripheral blood and/or skin biopsy samples from 26 SS patients (see Supplementary Table <ref type="table" target="#tab_0">S1</ref> online) and blood samples from 10 healthy volunteers were included in our study.</s><s>Diagnoses were established according to the World Health Organization/European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas <ref type="bibr" target="#b67">(Willemze et al., 2005)</ref>.</s><s>Written, informed patient consent was obtained, and the use of human material was approved by the local ethics committee of the Charite ´e Universitaetsmedizin Berlin (EA1/ 237/13) and performed in accordance with the Declaration of Helsinki.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cell lines and cell culture</head><p><s>Four human CTCL-derived cell lines (SeAx, Hut-78, MyLa, HH) and five cell lines derived from T-cell acute lymphoblastic leukemia (Jurkat, Molt-4, KE-37, CCRF, K45) were cultured at 37 C and 9% carbon dioxide in RPMI 1640 supplemented with 10% fetal bovine serum (Biochrom, Berlin, Germany), L-glutamine, and antibiotics (PAA, Parsching, Austria).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Enrichment of SS tumor cells and isolation of T-cell subsets from healthy donors</head><p><s>PBMCs were isolated as described before <ref type="bibr" target="#b56">(Steininger et al., 2011)</ref>.</s><s>For analysis of genomic and epigenetic alterations, CD4 þ T cells were enriched by direct magnetic separation by using CD4 MicroBeads <ref type="bibr">(Miltenyi Biotec, Bergisch Gladbach, Germany)</ref>.</s><s>As indicated in Supplementary Table <ref type="table" target="#tab_0">S1</ref>, some analyses where done from tumor cell samples presorted according to their clone-specific T-cell receptor Vb chain expressions, which have been published before <ref type="bibr" target="#b56">(Steininger et al., 2011)</ref>.</s><s>For gene expression analysis, CD4positive cells from SS patients and CD4 þ memory T cells from healthy donors were isolated by indirect sorting using the CD4 þ T-Cell Isolation Kit II and the Memory CD4 þ T-Cell Isolation Kit (Miltenyi Biotec).</s><s>All sorting was done according to the manufacturer's protocol.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Isolation of monocytes from SS patients</head><p><s>Monocytes were isolated from patients' PBMCs by adherence.</s><s>To this end, PBMCs were seeded at 37 C and 9% carbon dioxide in RPMI 1640 supplemented with 10% fetal bovine serum (Biochrom, Berlin, Germany), L-glutamine, and antibiotics (PAA, Parsching, Austria) in cell culture-grade culture flasks (BD Bioscience, Heidelberg, Germany).</s><s>After 3 hours, supernatants were discarded, and residual lymphocytes were removed by repeated washing with phosphate buffered saline.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Flow cytometric analysis of tumor cell samples</head><p><s>PBMCs or enriched tumor cells were analyzed on a FACSCalibur flow cytometer (BD Bioscience) by using CellQuest Pro (BD Bioscience) and WinMDI, version 2.9 (The Scripps Research Institute, La Jolla, CA).</s><s>Antibodies against CD3, CD4, and CD8 were from BD Bioscience.</s><s>All Vb chain-specific antibodies were from Beckman Coulter (Krefeld, Germany).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Detection of genomic imbalances</head><p><s>Genomic aberrations of 23 SS patients were analyzed by aCGH with a submegabase-resolution bacterial artificial chromosome array <ref type="bibr" target="#b19">(Erdogan et al., 2006)</ref> (six patients) or a whole-genome 400k oligonucleotide array (17 patients) (Agilent, Gene Expression Omnibus accession number GPL9777).</s><s>Of those 23 patients, comparative genomic hybridization data of 20 patients originated from <ref type="bibr" target="#b56">Steininger et al., 2011.</ref></s><s>Experimental and computational analyses were performed as described before <ref type="bibr" target="#b56">(Steininger et al., 2011)</ref>.</s><s>Comparative genomic hybridization data of the combined data set is available at the Gene Expression Omnibus (accession number GSE63013).</s></p><p><s>Interphase fluorescence in situ hybridization was performed on cell suspensions from patients and cell lines using the FISH Accessory Kit (Dako, Hamburg, Germany), a gene-specific probe for RUNX3, and a centromeric probe for chromosome 1 (both Empire Genomics, Buffalo, NY).</s><s>The slides were scanned with the BioView Allegro Plus System, and signals were evaluated using the Solo Software (BioView, Rehovot, Israel).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Sequencing of RUNX3</head><p><s>Genomic DNA was extracted using the PureLink Genomic DNA Mini Kit (Life Technologies, Thermo Fisher Scientific, Waltham, MA).</s><s>All seven exons of RUNX3 were amplified using AccuPrime GC-Rich DNA Polymerase (Life Technologies).</s><s>After purification, direct sequencing was performed with the BigDye A Haider et al.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Loss of RUNX3/p46 in Human T-Cell Lymphoma</head><p><s>Terminator, version 1.1, Cycle Sequencing Kit (Life Technologies), and subsequent capillary electrophoresis were performed on an ABI Prism 310 Genetic Analyzer (Life Technologies).</s><s>Primers were designed with Primer3Plus <ref type="bibr" target="#b60">(Untergasser et al., 2007)</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>(see Supplementary Table S2 online).</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Bisulfite sequencing of RUNX3 promoter regions</head><p><s>Genomic DNA was subjected to bisulfite conversion by using the EZ DNA Methylation-Gold Kit (Zymo Research, Freiburg, Germany) according to the manufacturer's instructions.</s><s>For analysis of RUNX3 promoter methylation, two regions, one within the distal promoter (e281 to e11 base pairs relative to ENST00000399916) and one within the proximal promoter (e611 to e373 base pairs relative to ENST00000308873) regions, were amplified from bisulfite-treated DNA using AmpliTaq Gold DNA Polymerase (Life Technologies).</s><s>Primers were designed using MethPrimer <ref type="bibr" target="#b43">(Li and Dahiya, 2002)</ref>, and M13 sequencing primer binding sites were added before the respective promoter-specific sequences (see Supplementary Table <ref type="table">S3</ref> online).</s><s>Subsequently, gel-purified PCR fragments were directly sequenced with M13 sequencing primers, as described.</s><s>Results were grouped into three categories: no methylation (&lt;10% signal), mixed (up to approximately 70%), and complete methylation (&gt;70%) of evaluable CpG sites.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Immunohistochemistry</head><p><s>After dewaxing of the tissue sections (4 mm) with xylene, antigen retrieval was performed by cooking for 2 minutes in citrate buffer (10 mmol/L, pH 6.0) in a pressure cooker.</s><s>The RUNX3 antibody (clone R3-5G4, Abcam, Cambridge, UK) was applied at a 1:200 dilution, and after incubation for 45 minutes at room temperature, the binding of the antibody was visualized with the help of the alkaline phosphatase anti-alkaline phosphatase method with FastRed as the chromogen (Dako, Hamburg, Germany).</s></p><p><s>Immunofluorescence microscopy 1 Â 10 5 cells were spun onto StarFrost adhesive slides (Knittel, Braunschweig, Germany), fixed with phosphate buffered saline containing 3.7% formaldehyde for 15 minutes at room temperature and blocked with 10% normal donkey serum in phosphate buffered saline containing 0.3% Triton X-100 (SERVA Electrophoresis GmbH, Heidelberg, Germany) for 1 hour.</s><s>Slides where incubated with mouse anti-human RUNX3/CBFA3 antibody (MAB3765, R&amp;D Systems, Minneapolis, MN; 1:50) in blocking solution for 1 hour, washed three times with 0.1% BSA in phosphate buffered saline, incubated with Alexa Fluor 594 Donkey Anti-Mouse IgG (Molecular Probes, Thermo Fisher Scientific, Braunschweig, Germany; 1:800) in blocking solution for 1 hour, and washed three times with washing buffer.</s><s>Nuclei were counterstained with DAPI.</s><s>Slides were analyzed by using an Axioplan2 fluorescence microscope (Zeiss, Oberkochen, Germany).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Generation of protein extracts</head><p><s>For generation of whole-cell extracts, cells were lysed in 0.01 mol/L Tris-HCl, pH 7.5; 0.144 mol/L NaCl; 0.5% Igepal CA 630 (Sigma-Aldrich, Munich, Germany); and 0.5% SDS, with protease/phosphatase inhibitors (Roche, Mannheim, Germany) and sonicated for 4 seconds.</s><s>Lysates were centrifuged at 14,000g for 10 minutes at 4 C, and supernatants were transferred to new tubes.</s><s>The generation of nuclear and cytoplasmic protein extracts was performed using the Nuclear Extraction Kit (Active Motive, La Hulpe, Belgium) as recommended by the manufacturer.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Western blot analysis</head><p><s>For Western blot analysis, 25 mg of protein were separated on 12.5% polyacrylamide gels.</s><s>Protein was transferred to nitrocellulose membranes (Whatman, Maidstone, UK) by electroblotting.</s><s>Membranes were blocked with 5% nonfat dry milk in Tris-buffered saline containing 0.1% Tween-20 (i.e., TBST).</s><s>After incubation with different primary antibodies, proteins were visualized by enhanced chemiluminescence (Pierce ECL Plus Western Blotting Substrate, Thermo Fisher Scientific) using horseradish peroxidaseconjugated anti-mouse secondary antibodies (Dako).</s><s>Primary antibodies and their respective dilutions are listed in Supplementary Table <ref type="table">S4</ref> online.</s><s>Where indicated, membranes were stripped by shaking for 15 minutes in 0.625 M Tris-HCl, pH 6.8, containing 2% SDS and 0.1 mol/L 2-mercaptoethanol at 56 C followed by washing six times for 5 minutes with TBST and reused for incubation with different antibodies.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Gene expression analysis</head><p><s>Total RNA was isolated using the QiaAmp RNA Blood Mini Kit (Qiagen, Hilden, Germany) with on-column DNase I digestion (RNase free DNase Set, Qiagen) according to the manufacturer's instructions.</s><s>RNA concentration was determined by Qubit RNA BR assay (Life Technologies).</s><s>To assess the quality of total RNA of each sample, extracted RNA was tested using the Agilent Bioanalyzer 2100 (Agilent Technologies, Santa Clara, CA).</s><s>Based on this, highquality RNA was available in 11 of 21 patients with SS. cDNA was generated from approximately 0.6 mg total RNA using the "You-Prime first-strand Beads" (GE Healthcare, Freiburg, Germany) with random hexamer primers according to the manufacturer's protocol.</s><s>Quantitative real-time reverse transcriptaseePCR was performed from 2 ml of a 1:5 dilution of cDNA on a LightCycler 2.0 instrument using TaqMan Gene Expression Master Mix and TaqMan Gene Expression Assays (Life Technologies).</s><s>TATA-box binding protein expression was used for normalization.</s><s>Each reaction was performed in triplicates.</s><s>Reaction efficiencies were calculated by serial dilutions of cDNA.</s><s>Efficiency-corrected normalization of gene expression was done using Q-Gene 1.2 <ref type="bibr" target="#b47">(Muller et al., 2002)</ref>.</s><s>Differential expression between SS tumor cells and healthy control samples was assessed by pair-wise randomization test with 10,000 permutations using REST Software 2009, version 2.0.13 (Qiagen) in RG mode with PCR efficiencies as calculated above <ref type="bibr" target="#b52">(Pfaffl et al., 2002)</ref>.</s><s>The respective TaqMan Gene Expression Assay and annealing temperatures are listed in Supplementary Table <ref type="table">S5</ref> online.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Plasmid construction and nucleofection</head><p><s>The RUNX3/p46 expression construct was synthesized by GeneArt (Thermo Fisher Scientific).</s><s>It is composed of the RUNX3/p46 coding sequence C-terminally fused to a SH-tag consisting of a streptavidinbinding peptide and a hemagglutinin epitope tag (modified after <ref type="bibr" target="#b23">Glatter et al., 2009)</ref>.</s><s>The construct then was subcloned into pMAX (Lonza, Basel, Switzerland).</s><s>For nucleofection, plasmids were purified using the Zyppy Plasmid Maxiprep Kit (Zymo Research), and 2 Â 10 6 cells were transfected with 20 mg of plasmid using a Nucleofector 2b device with Cell Line Nucleofector Kit V (Lonza) and program X-001.</s><s>Nucleofection efficiency was assessed by parallel transfection with pMAX-GFP (Lonza) and subsequent analysis of green fluorescent protein expression by flow cytometry.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cell viability assay</head><p><s>Forty-eight hours after nucleofection, living/dead cell counts were obtained using a hemocytometer to count trypan blue-negative/-positive cells.</s><s>Viability was further evaluated by seeding 15,000 trypan blue-negative cells on 96-well plates and assessing the number of viable cells after another 48 hours using cell proliferation reagent WST-1 (Roche).</s><s>Each experiment was performed in triplicate.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Detection of apoptosis and cell cycle analysis</head><p><s>Detection of apoptosis and enumeration of proliferating cells was done by determination of DNA content using propidium iodide.</s><s>To this end, cells were harvested by centrifugation, resuspended in cold phosphate buffered saline, fixed with prechilled ethanol at e20 C for at least 24 hours, and stained for 40 minutes in 500 ml of a staining solution containing propidium iodide (50 mg/ml), RNase A (0.1 mg/ml), and 0.05% Triton X-100.</s><s>Apoptotic cells (Sub-G1 population) and proliferating cells (cells in S-phase plus cells in G2 phase) were determined by flow cytometry on a FACSCalibur flow cytometer using Cell-Quest Pro (BD Bioscience) and Flowing Software, version 2.5 (Cell Imaging Core, Turku Centre for Biotechnology, Turku, Finland).</s><s>Induction of apoptosis was confirmed by Western blot analysis of cleaved caspase-3.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 .</head><label>1</label><figDesc><div><p><s>Figure 1.</s><s>Structure of the human RUNX3 locus and the transcripts coding for RUNX3/p47 and RUNX3/ p44.</s><s>The boxes represent the different exons.</s><s>Translated regions are marked in light grey.</s><s>Dark grey areas indicate the localization of the DNA-binding Runt domain.</s><s>Dotted lines indicate that the untranslated part of the last exon is not entirely displayed.</s><s>*Initiation codons.</s><s>P1, distal promoter; P2, proximal promoter.</s></p></div></figDesc><graphic coords="2,215.09,54.31,335.95,123.36" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 2 .</head><label>2</label><figDesc><div><p><s>Figure 2. RUNX3 is inactivated by genomic deletion and promoter methylation but not by cytoplasmic retention.</s><s>(a) Physical position and frequency of genomic aberrations at chromosome 1 in tumor cells of 23 SS patients.</s><s>Gains and losses at chromosome 1 are plotted according to their</s></p></div></figDesc><graphic coords="3,43.94,54.31,245.28,637.00" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>2A</head><label></label><figDesc><div><p><s>e symbol indicates no mutation or single-nucleotide polymorphism.3</s><s>A e symbol indicates no methylation; (þ) indicates mixed methylation pattern; þ indicates &gt;70% methylation of analyzed CpGs. 4 Between three and six copies of centromere 1, but always two signals for RUNX3.</s><s>5 Trisomy of chromosome 1 including RUNX3.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head></head><label></label><figDesc><div><p><s>6</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Figure 3 .</head><label>3</label><figDesc><div><p><s>Figure 3. RUNX3 gene expression analysis in SS tumor cells.</s><s>(a) Quantification of RUNX3/p46 mRNA levels in CD4-enriched blood circulating SS cells from 11 patients and CD4 þ memory T cells from healthy volunteers, as indicated.</s><s>RUNX3 mRNA expression from the distal promoter was analyzed relative to TBP by quantitative real-time PCR using primers recognizing only RUNX3/p46.</s><s>Error bars indicate standard error of the mean normalized expression values of three technical replicates.</s><s>The presence of RUNX3 deletions, methylation of the distal promoter (P1 meth.), and presence of rs6672420 (SNP) is depicted below each SS sample.</s><s>(b) RUNX3 mRNA expression was analyzed as in a, with primers recognizing RUNX3/ p46 and RUNX3/p44.</s><s>(c) Whisker-box plots of the relative RUNX3 mRNA expression ratios between SS samples and healthy control samples as measured in a (left) and b (right).</s><s>The expression ratios between both groups as well as P-values were calculated with REST 2009, version 2.0.13.</s><s>The dotted line represents the median relative expression value in SS tumor cells, the box area encompasses 50% of all observations, and the whiskers represent the outer 50% of observations.</s><s>(d) Quantification of RUNX3 mRNA levels in four CTCL cell lines and the T-ALL cell line Jurkat.</s><s>Relative expression to TBP was analyzed by real-time PCR with primers recognizing both RUNX3 transcripts (RUNX3, black bars) or only RUNX3/p46 mRNA (white bars).</s><s>Error bars indicate standard error of the mean normalized expression values of three technical replicates.</s><s>Note the different scaling of y-axes in the subfigures.</s><s>CTCL, cutaneous T-cell lymphoma; P1 meth., methylation of the distal promoter; SNP, single-nucleotide polymorphism; SS, Se ´zary syndrome; T-ALL, T-cell acute lymphoblastic leukemia; TBP, TATA-box binding protein.=</s></p></div></figDesc><graphic coords="5,43.94,54.31,245.28,616.59" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head>Figure 4 .</head><label>4</label><figDesc><div><p><s>Figure 4. Reconstitution of RUNX3/p46 expression in MyLa cells.</s><s>(a) MyLa cells were transfected with a C-terminally HA-tagged RUNX3/p46 expression construct or empty vector (MOCK).</s><s>At 48 hours after transfection, the proportion of dead cells was visualized by trypan blue staining.</s><s>The y-axis shows the percentage of trypan blue-positive cells.</s><s>Error bars indicate the standard deviation of five independent experiments performed in triplicate.</s><s>(b) MyLa cells were treated as in a, and the percentage of apoptotic cells was determined by staining of ethanol-fixed cells with propidium iodide and subsequent flow cytometry.</s><s>Values are given as percentage of apoptotic cells (SubG1 population).</s><s>Error bars indicate standard deviation of four independent experiments performed in triplicate.</s><s>(c) Histogram plots of one representative experiment, as shown in b, also showing the fraction of cells in the different cell cycle phases depicted in percentage of overall cells.</s><s>(d) Western blot analysis of RUNX3/p46 or MOCK transfected MyLa cells.</s><s>Cells were treated as in a. Upper lane, analysis of RUNX3/p46 protein expression by anti-HA antibody showing a robust expression of the transgene.</s><s>Middle lane, analysis of caspase-3 cleaving products (p19, p17) showing a further procession of p19 to the highly active p17 cleavage product in RUNX3/p46 transfected MyLa cells.</s><s>Lower lane, GAPDH protein expression showed equal loading of both samples.</s><s>All proteins were visualized on one identical membrane after stripping and re-incubation with the respective primary antibodies.</s><s>(e) Equal numbers of untransfected, MOCK transfected, and RUNX3/p46 transfected trypan blue-negative cells were cultivated for another 24 hours and the numbers of viable cells were determined by WST-1.</s><s>Values are given as percentages relative to untransfected cells.</s><s>Error bars indicate standard deviation of four independent experiments performed in triplicates.</s><s>*P 0.05.</s><s>**P 0.01.</s><s>All P-values were calculated by two-sided t test.</s><s>Csp-3, caspase-3; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; MOCK, empty vector control; WST-1, water soluble tetrazolium-1.</s></p></div></figDesc><graphic coords="6,255.12,54.31,295.88,403.60" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 .</head><label>1</label><figDesc><div><p><s>Results of genomic analyses in SS tumor samples</s></p></div></figDesc><table><row><cell></cell><cell cols="2">Heterozygous Loss of RUNX3 1</cell><cell cols="2">RUNX3 Sequencing Results 2</cell><cell></cell></row><row><cell>SS Patient/Cell Line</cell><cell>Array CGH</cell><cell>FISH</cell><cell>Tumor Cells</cell><cell>Monocytes</cell><cell>Methylation Pattern of RUNX3-P1 3</cell></row><row><cell>1</cell><cell>e</cell><cell>n.d.</cell><cell>e</cell><cell>n.d.</cell><cell>e</cell></row><row><cell>2</cell><cell>þ</cell><cell>n.d.</cell><cell>e</cell><cell>n.d.</cell><cell>e</cell></row><row><cell>3</cell><cell>þ</cell><cell>n.d.</cell><cell>e</cell><cell>n.d.</cell><cell>(þ)</cell></row><row><cell>4</cell><cell>e</cell><cell>n.d.</cell><cell>e</cell><cell>n.d.</cell><cell>(þ)</cell></row><row><cell>5</cell><cell>þ</cell><cell>69/100</cell><cell>e</cell><cell>n.d.</cell><cell>e</cell></row><row><cell>6</cell><cell>þ</cell><cell>66/100</cell><cell>e</cell><cell>n.d.</cell><cell>e</cell></row><row><cell>7</cell><cell>þ</cell><cell>85/100</cell><cell>e</cell><cell>n.d.</cell><cell>þ</cell></row><row><cell>8</cell><cell>e</cell><cell>n.d.</cell><cell>rs6672420 (MSV; het.)</cell><cell>rs6672420 (MSV; het.)</cell><cell>e</cell></row><row><cell>9</cell><cell>e</cell><cell>n.d.</cell><cell>e</cell><cell>n.d.</cell><cell>n.d.</cell></row><row><cell>10</cell><cell>e</cell><cell>n.d.</cell><cell>rs6672420 (MSV; het.)</cell><cell>n.d.</cell><cell>þ</cell></row><row><cell>11</cell><cell>þ</cell><cell>n.d.</cell><cell>e</cell><cell>n.d.</cell><cell>e</cell></row><row><cell>12</cell><cell>e</cell><cell>n.d.</cell><cell>rs6672420 (MSV; het.)</cell><cell>n.d.</cell><cell>þ</cell></row><row><cell>13</cell><cell>e</cell><cell>n.d.</cell><cell>rs6672420 (MSV; hom.)</cell><cell>n.d.</cell><cell>(þ)</cell></row><row><cell>14</cell><cell>e</cell><cell>n.d.</cell><cell>e</cell><cell>n.d.</cell><cell>e</cell></row><row><cell>15</cell><cell>e</cell><cell>n.d.</cell><cell>rs6672420 (MSV; hom.)</cell><cell>rs6672420 (MSV; hom.)</cell><cell>e</cell></row><row><cell>16</cell><cell>e</cell><cell>n.d.</cell><cell>rs6672420 (MSV; hom.)</cell><cell>rs6672420 (MSV; hom.)</cell><cell>(þ)</cell></row><row><cell>17</cell><cell>e</cell><cell>n.d.</cell><cell>rs6672420 (MSV; het.)</cell><cell>rs6672420 (MSV; het.)</cell><cell>e</cell></row><row><cell>18</cell><cell>þ</cell><cell>n.d.</cell><cell>n.d.</cell><cell>n.d.</cell><cell>n.d.</cell></row><row><cell>19</cell><cell>þ</cell><cell>11/100</cell><cell>e</cell><cell>n.d.</cell><cell>(þ)</cell></row><row><cell>20</cell><cell>e</cell><cell>n.d.</cell><cell>rs6672420 (MSV; het.)</cell><cell>rs6672420 (MSV; het.)</cell><cell>þ</cell></row><row><cell>21</cell><cell>e</cell><cell>n.d.</cell><cell>e</cell><cell>n.d.</cell><cell>þ</cell></row><row><cell>22</cell><cell>e</cell><cell>n.d.</cell><cell>rs6672420 (MSV; het.)/</cell><cell>rs6672420 (MSV; het.)/</cell><cell>e</cell></row><row><cell></cell><cell></cell><cell></cell><cell>rs143410594 (SyV; het.)</cell><cell>rs143410594 (SyV; het.)</cell><cell></cell></row><row><cell>23</cell><cell>þ</cell><cell>62/100</cell><cell>e</cell><cell>n.d.</cell><cell>e</cell></row><row><cell>24</cell><cell>n.d.</cell><cell>n.d.</cell><cell>e</cell><cell>n.d.</cell><cell>e</cell></row><row><cell>25</cell><cell>n.d.</cell><cell>n.d.</cell><cell>e</cell><cell>n.d.</cell><cell>þ</cell></row><row><cell>26</cell><cell>n.d.</cell><cell>n.d.</cell><cell>e</cell><cell>n.d.</cell><cell>e</cell></row><row><cell>SeAx</cell><cell>þ</cell><cell>45/45 4</cell><cell>rs6672420 (MSV; het.)</cell><cell>n.a.</cell><cell>e</cell></row><row><cell>Hut-78</cell><cell>e</cell><cell>0/40 5</cell><cell>rs6672420 (MSV; het.)</cell><cell>n.a.</cell><cell>e</cell></row><row><cell>MyLa</cell><cell>e</cell><cell>0/35</cell><cell>n.d.</cell><cell>n.a.</cell><cell>þ</cell></row><row><cell>HH</cell><cell>gain</cell><cell>12/40 (loss), 17/40 (gain) 6</cell><cell>n.d.</cell><cell>n.a.</cell><cell></cell></row></table><note><p><s>e Abbreviations: CGH, comparative genomic hybridization; FISH, fluorescence in situ hybridization; het., heterozygous single-nucleotide polymorphism; hom., homozygous single-nucleotide polymorphism; MSV, missense variant; n.a., not applicable; n.d., not done; P1, distal promoter; SS, Se ´zary syndrome; SyV, synonymous variant.1 A e symbol indicates no deletion; þ indicates heterozygous deletion of RUNX3.</s></p></note></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">Journal of Investigative Dermatology (2016), Volume 136</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">www.jidonline.org 2289</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">www.jidonline.org 2291</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">www.jidonline.org 2293</note>
		</body>
		<back>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>CONFLICT OF INTEREST</head><p><s>The authors state no conflict of interest.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ACKNOWLEDGMENTS</head><p><s>Funding was provided by the Wilhelm-Sander Stiftung (2011-066.1),</s><s>Verein der Freunde der Dermatologischen Klinik Krefeld e.V., and the Charite ´e Universitaetsmedizin Berlin.</s><s>We thank Frank H. Braun, Michael Plo ¨tz, Ju ¨rgen Eberle, Brita Scholte, Katja Steinhorst, Hans-Henning Mu ¨ller, and Stefanie Mende for their helpful advice and assistance.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>SUPPLEMENTARY MATERIAL</head><p><s>Supplementary material is linked to the online version of the paper at www. jidonline.org,</s><s>and at http://dx.doi.org/10.1016/j.jid.2016.05.126.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Variants in RUNX3 contribute to susceptibility to psoriatic arthritis, exhibiting further common ground with ankylosing spondylitis</title>
		<author>
			<persName><forename type="first">M</forename><surname>Apel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Uebe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bowes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Giardina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Korendowych</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Juneblad</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arthritis Rheum</title>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="page" from="1224" to="e1231" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">The RUNX3 geneesequence, structure and regulated expression</title>
		<author>
			<persName><forename type="first">C</forename><surname>Bangsow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Rubins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Glusman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Bernstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Negreanu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Goldenberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gene</title>
		<imprint>
			<biblScope unit="volume">279</biblScope>
			<biblScope unit="page" from="221" to="e232" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Differential expression of TOX by skin-infiltrating T cells in Se ´zary syndrome and erythrodermic dermatitis</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Boonk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>¸etino ¨zman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Vermeer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Jansen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Willemze</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cutan Pathol</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="604" to="e609" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Tumor suppressor TNFAIP3 (A20) is frequently deleted in Sezary syndrome</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">C</forename><surname>Braun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Grabarczyk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mo ¨bs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">K</forename><surname>Braun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Eberle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Beyer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Leukemia</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="1494" to="e501" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Interferon regulatory factor 4 regulates thymocyte differentiation by repressing Runx3 expression</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Cao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Gao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Immunol</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="3198" to="e209" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Reduced surface expression of transforming growth factor beta receptor type II in mitogen-activated T cells from Sezary patients</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Capocasale</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Lamb</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">C</forename><surname>Vonderheid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">E</forename><surname>Fox</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">H</forename><surname>Rook</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Nowell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">92</biblScope>
			<biblScope unit="page" from="5501" to="e5505" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">RUNX3 suppresses migration, invasion and angiogenesis of human renal cell carcinoma</title>
		<author>
			<persName><forename type="first">F</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Mei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Li</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">e56241</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Novel roles for MLH3 deficiency and TLE6-like amplification in DNA mismatch repair-deficient gastrointestinal tumorigenesis and progression</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kuraguchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Velasquez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Edwards</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS Genet</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page">e1000092</biblScope>
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">RUNX3 suppresses gastric epithelial cell growth by inducing p21(WAF1/Cip1) expression in cooperation with transforming growth factor b-activated SMAD</title>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">Z</forename><surname>Chi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">O</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">Y</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Ito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Sakakura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><forename type="middle">L</forename><surname>Li</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Cell Biol</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="8097" to="e107" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Genomic landscape of cutaneous T cell lymphoma</title>
		<author>
			<persName><forename type="first">J</forename><surname>Choi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Goh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Walradt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">S</forename><surname>Hong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">G</forename><surname>Bunick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Chen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="page" from="1011" to="e1019" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">RUNX3 is multifunctional in carcinogenesis of multiple solid tumors</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Chuang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Ito</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncogene</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="2605" to="e2615" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">The Runx3 distal transcript encodes an additional transcriptional activation domain</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">D</forename><surname>Chung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Honda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Cafuir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mcduffie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Wotton</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">FEBS J</title>
		<imprint>
			<biblScope unit="volume">274</biblScope>
			<biblScope unit="page" from="3429" to="e3439" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">The mutational landscape of cutaneous T cell lymphoma and Sezary syndrome</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Da Silva Almeida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Abate</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Khiabanian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Martinez-Escala</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Guitart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">P</forename><surname>Tensen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="page" from="1465" to="1e70" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Infrequent Fas mutations but no Bax or p53 mutations in early mycosis fungoides: a possible mechanism for the accumulation of malignant T lymphocytes in the skin</title>
		<author>
			<persName><forename type="first">O</forename><surname>Dereure</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Levi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">C</forename><surname>Vonderheid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Kadin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Invest Dermatol</title>
		<imprint>
			<biblScope unit="volume">118</biblScope>
			<biblScope unit="page" from="949" to="e56" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Transcription factors T-bet and Runx3 cooperate to activate Ifng and silence Il4 in T helper type 1 cells</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">M</forename><surname>Djuretic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Levanon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Negreanu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Groner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Ansel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Immunol</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="145" to="e53" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<monogr>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">O</forename><surname>Dulmage</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Akilov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Vu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">D</forename><surname>Falo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Geskin</surname></persName>
		</author>
		<title level="m">Dysregulation of the TOX-RUNX3 pathway in cutaneous T-cell lymphoma</title>
				<imprint/>
	</monogr>
	<note>e-pub ahead of print</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title/>
		<idno type="DOI">10.18632/oncotarget.5742</idno>
		<ptr target="http://dx.doi.org/10.18632/oncotarget.5742" />
	</analytic>
	<monogr>
		<title level="j">Oncotarget</title>
		<imprint>
			<biblScope unit="page">26</biblScope>
			<date type="published" when="2015-03">2015. March 2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Interferon resistance of cutaneous T-cell lymphoma-derived clonal T-helper 2 cells allows selective viral replication</title>
		<author>
			<persName><forename type="first">R</forename><surname>Dummer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Dobbeling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Geertsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Willers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Burg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Pavlovic</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="page" from="523" to="e527" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">ThPOK acts late in specification of the helper T cell lineage and suppresses Runx-mediated commitment to the cytotoxic T cell lineage</title>
		<author>
			<persName><forename type="first">T</forename><surname>Egawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Littman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Immunol</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="1131" to="e1139" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Impact of low copy repeats on the generation of balanced and unbalanced chromosomal aberrations in mental retardation</title>
		<author>
			<persName><forename type="first">F</forename><surname>Erdogan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kirchhoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">M</forename><surname>Kalscheuer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Hultschig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Muller</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cytogenet Genome Res</title>
		<imprint>
			<biblScope unit="volume">115</biblScope>
			<biblScope unit="page" from="247" to="e53" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">RUNX3 promoter hypermethylation is frequent in leukaemia cell lines and associated with acute myeloid leukaemia inv(16) subtype</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Estecio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Maddipoti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bueso-Ramos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Dinardo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wei</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Haematol</title>
		<imprint>
			<biblScope unit="volume">169</biblScope>
			<biblScope unit="page" from="344" to="e51" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Evans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Spencer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Pointon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Su</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Harvey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Kochan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="761" to="e767" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">P</forename><surname>Flicek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Amode</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Barrell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Beal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Billis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Brent</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Res</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="D749" to="De55" />
			<date type="published" when="2014">2014. 2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">An integrated workflow for charting the human interaction proteome: insights into the PP2A system</title>
		<author>
			<persName><forename type="first">T</forename><surname>Glatter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Wepf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Aebersold</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gstaiger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Syst Biol</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page">237</biblScope>
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Runx3 regulates integrin alpha E/CD103 and CD4 expression during development of CD4-/CD8þ T cells</title>
		<author>
			<persName><forename type="first">B</forename><surname>Grueter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Petter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Egawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Laule-Kilian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Aldrian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Wuerch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">175</biblScope>
			<biblScope unit="page" from="1694" to="e705" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">TH2 cytokines from malignant cells suppress TH1 responses and enforce a global TH2 bias in leukemic cutaneous T-cell lymphoma</title>
		<author>
			<persName><forename type="first">E</forename><surname>Guenova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Watanabe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Teague</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Desimone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Dowlatshahi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Cancer Res</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="3755" to="3e63" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">DNA methylation directly silences genes with non-CpG island promoters and establishes a nucleosome occupied promoter</title>
		<author>
			<persName><forename type="first">H</forename><surname>Han</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Cortez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">W</forename><surname>Nichols</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Jones</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Liang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hum Mol Genet</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="4299" to="e310" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Thymocyte selection-associated high mobility group box gene (TOX) is aberrantly overexpressed in mycosis fungoides and correlates with poor prognosis</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">V</forename><surname>Litvinov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Su</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Tu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Jiang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncotarget</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="4418" to="e4425" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Evidence of an oncogenic role of aberrant TOX activation in cutaneous T-cell lymphoma</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Su</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">125</biblScope>
			<biblScope unit="page" from="1435" to="e1443" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">RUNX3 attenuates beta-catenin/T cell factors in intestinal tumorigenesis</title>
		<author>
			<persName><forename type="first">K</forename><surname>Ito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Lim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Salto-Tellez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Motoda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Osato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Chuang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Cell</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="226" to="e237" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">RUNX transcription factors as key targets of TGF-beta superfamily signaling</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Ito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Miyazono</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Genet Dev</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="43" to="e47" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Genomewide DNA methylation patterns in CD4þ T cells from patients with systemic lupus erythematosus</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Jeffries</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Dozmorov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Tang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Merrill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Wren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">H</forename><surname>Sawalha</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Epigenetics</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="593" to="e601" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<monogr>
		<title level="m" type="main">Progression of lymphomatoid papulosis to systemic lymphoma is associated with escape from growth inhibition by</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Kadin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Levi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Kempf</surname></persName>
		</author>
		<editor>A Haider et al.</editor>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<monogr>
		<ptr target="www.jidonline.org2295" />
		<title level="m">Loss of RUNX3/p46 in Human T-Cell Lymphoma</title>
				<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">transforming growth factor-beta and CD30 ligand</title>
	</analytic>
	<monogr>
		<title level="j">Ann N Y Acad Sci</title>
		<imprint>
			<biblScope unit="volume">941</biblScope>
			<biblScope unit="page" from="59" to="e68" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Establishment of two continuous T-cell strains from a single plaque of a patient with mycosis fungoides</title>
		<author>
			<persName><forename type="first">K</forename><surname>Kaltoft</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Bisballe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Dyrberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Boel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">B</forename><surname>Rasmussen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Thestrup-Pedersen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">In Vitro Cell Dev Biol</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="161" to="e167" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Early mycosis fungoides: molecular analysis for its diagnosis and the absence of p53 gene mutations in cases with progression</title>
		<author>
			<persName><forename type="first">S</forename><surname>Kapur</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Menke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Tiemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Schubert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Parwaresch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Dermatol Sci</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="36" to="e45" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Genomic analyses reveal recurrent mutations in epigenetic modifiers and the JAK-STAT pathway in Sezary syndrome</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Kiel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Sahasrabuddhe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Rolland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Velusamy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Chung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Schaller</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Commun</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page">8470</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Oncogene-induced senescence: an essential role for Runx</title>
		<author>
			<persName><forename type="first">A</forename><surname>Kilbey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Terry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">R</forename><surname>Cameron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Neil</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Cycle</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="2333" to="e2340" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">The Runx3 transcription factor augments Th1 and down-modulates Th2 phenotypes by interacting with and attenuating GATA3</title>
		<author>
			<persName><forename type="first">K</forename><surname>Kohu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Ohmori</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">F</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Onda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Wakoh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">183</biblScope>
			<biblScope unit="page" from="7817" to="e7824" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">The tumour suppressor p53 is frequently nonfunctional in Sezary syndrome</title>
		<author>
			<persName><forename type="first">B</forename><surname>Lamprecht</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kreher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mo ¨bs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Sterry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Do ¨rken</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Janz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Dermatol</title>
		<imprint>
			<biblScope unit="volume">167</biblScope>
			<biblScope unit="page" from="240" to="e246" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Dysregulated synthesis of intracellular type 1 and type 2 cytokines by T cells of patients with cutaneous T-cell lymphoma</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">N</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Duvic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Tang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bueso-Ramos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Estrov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Reuben</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Diagn Lab Immunol</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="79" to="e84" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Transcriptome sequencing in Sezary syndrome identifies Sezary cell and mycosis fungoides-associated lncRNAs and novel transcripts</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ungewickell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bhaduri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Qu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Webster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Armstrong</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">120</biblScope>
			<biblScope unit="page" from="3288" to="3e97" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">MethPrimer: designing primers for methylation PCRs</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Dahiya</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bioinformatics</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="1427" to="e1431" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Causal relationship between the loss of RUNX3 expression and gastric cancer</title>
		<author>
			<persName><forename type="first">Q</forename><forename type="middle">L</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Ito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Sakakura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Fukamachi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Inoue</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">Z</forename><surname>Chi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">109</biblScope>
			<biblScope unit="page" from="113" to="e124" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Analysis of PPARGC1B, RUNX3 and TBKBP1 polymorphisms in Chinese Han patients with ankylosing spondylitis: a case-control study</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Lian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Chai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">L</forename><surname>Shi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page">e61527</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Increased genetic susceptibility to intestinal-type gastric cancer is associated with increased activity of the RUNX3 distal promoter</title>
		<author>
			<persName><forename type="first">B</forename><surname>Lim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Ju</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Kang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer</title>
		<imprint>
			<biblScope unit="volume">117</biblScope>
			<biblScope unit="page" from="5161" to="5e71" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Processing of gene expression data generated by quantitative real-time RT-PCR</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">Y</forename><surname>Muller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Janovjak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Miserez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Dobbie</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biotechniques</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="8" to="e9" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Repression of interleukin-4 in T helper type 1 cells by Runx/Cbf beta binding to the Il4 silencer</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Naoe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Setoguchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Akiyama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Muroi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kuroda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Hatam</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">204</biblScope>
			<biblScope unit="page" from="1749" to="1e55" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Absence of somatic mutations within the Runt domain of AML2/RUNX3 in acute myeloid leukaemia</title>
		<author>
			<persName><forename type="first">F</forename><surname>Otto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Stock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Fliegauf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Fenaux</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Preudhomme</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lubbert</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Leukemia</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="1677" to="e1678" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Signaling by intrathymic cytokines, not T cell antigen receptors, specifies CD8 lineage choice and promotes the differentiation of cytotoxic-lineage T cells</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Adoro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Guinter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Erman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Alag</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Catalfamo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Immunol</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="257" to="e64" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">RUNX3 inhibits the expression of vascular endothelial growth factor and reduces the angiogenesis, growth, and metastasis of human gastric cancer</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Peng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Wei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Tang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Le</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Cancer Res</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="6386" to="6e94" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Pfaffl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">W</forename><surname>Horgan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Dempfle</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Res</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page">e36</biblScope>
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">The novel RUNX3/ p33 isoform is induced upon monocyte-derived dendritic cell maturation and downregulates IL-8 expression</title>
		<author>
			<persName><forename type="first">A</forename><surname>Puig-Kroger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Aguilera-Montilla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Martinez-Nunez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Dominguez-Soto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Sanchez-Cabo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Martin-Gayo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunobiology</title>
		<imprint>
			<biblScope unit="volume">215</biblScope>
			<biblScope unit="page" from="812" to="e820" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Possible involvement of RUNX3 silencing in the peritoneal metastases of gastric cancers</title>
		<author>
			<persName><forename type="first">C</forename><surname>Sakakura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Hasegawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Miyagawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Nakashima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Yoshikawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Cancer Res</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="6479" to="6e88" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Sequential polarization and imprinting of type 1 T helper lymphocytes by interferon-gamma and interleukin-12</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">G</forename><surname>Schulz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Mariani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Radbruch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Hofer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunity</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="673" to="e83" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">Genomic loss of the putative tumor suppressor gene E2A in human lymphoma</title>
		<author>
			<persName><forename type="first">A</forename><surname>Steininger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mo ¨bs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Ullmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Ko ¨chert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kreher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Lamprecht</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">208</biblScope>
			<biblScope unit="page" from="1585" to="1e93" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Runx3 interacts with DNA repair protein Ku70</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Tanaka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Imamura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Kanai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ichimura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Isobe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Koike</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Exp Cell Res</title>
		<imprint>
			<biblScope unit="volume">313</biblScope>
			<biblScope unit="page" from="3251" to="3e60" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development</title>
		<author>
			<persName><forename type="first">I</forename><surname>Taniuchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Osato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Egawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Sunshine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Bae</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Komori</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">111</biblScope>
			<biblScope unit="page" from="621" to="e633" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Tsoi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Spain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Knight</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Ellinghaus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>Stuart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Capon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="1341" to="e1348" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">Pri-mer3Plus, an enhanced web interface to Primer3</title>
		<author>
			<persName><forename type="first">A</forename><surname>Untergasser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Nijveen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Rao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Bisseling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Geurts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Leunissen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Res</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="W71" to="e74" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note>Web Server issue</note>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">Aberrant expression of the tyrosine kinase receptor EphA4 and the transcription factor twist in Sezary syndrome identified by gene expression analysis</title>
		<author>
			<persName><forename type="first">R</forename><surname>Van Doorn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Dijkman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Vermeer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Out-Luiting</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Van Der Raaij-Helmer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Willemze</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="page" from="5578" to="5e86" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main">Epigenetic profiling of cutaneous T-cell lymphoma: promoter hypermethylation of multiple tumor suppressor genes including BCL7a, PTPRG, and p73</title>
		<author>
			<persName><forename type="first">R</forename><surname>Van Doorn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">H</forename><surname>Zoutman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Dijkman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">X</forename><surname>De Menezes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Commandeur</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Mulder</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Oncol</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="3886" to="3e96" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main">Aberrant cytokine production by Sezary syndrome patients: cytokine secretion pattern resembles murine Th2 cells</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">R</forename><surname>Vowels</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Cassin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">C</forename><surname>Vonderheid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">H</forename><surname>Rook</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Invest Dermatol</title>
		<imprint>
			<biblScope unit="volume">99</biblScope>
			<biblScope unit="page" from="90" to="e94" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main">Genomic profiling of Sezary syndrome identifies alterations of key T cell signaling and differentiation genes</title>
		<author>
			<persName><forename type="first">L</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Ni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">R</forename><surname>Covington</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">Y</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Shiu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Zhang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="page" from="1426" to="e1434" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main">Inhibition of Pim1 kinase prevents peanut allergy by enhancing Runx3 expression and suppressing T(H)2 and T(H)17 T-cell differentiation</title>
		<author>
			<persName><forename type="first">M</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Okamoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Domenico</forename><forename type="middle">J</forename><surname>Han</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ashino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Shin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">S</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">130</biblScope>
			<biblScope unit="page" from="932" to="e944" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title level="a" type="main">RUNX3 Controls a Metastatic Switch in Pancreatic Ductal Adenocarcinoma</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Whittle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Izeradjene</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">G</forename><surname>Rani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Feng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Carlson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">E</forename><surname>Delgiorno</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">161</biblScope>
			<biblScope unit="page" from="1345" to="1e60" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b67">
	<analytic>
		<title level="a" type="main">WHO-EORTC classification for cutaneous lymphomas</title>
		<author>
			<persName><forename type="first">R</forename><surname>Willemze</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">S</forename><surname>Jaffe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Burg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Cerroni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Berti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Swerdlow</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">105</biblScope>
			<biblScope unit="page" from="3768" to="3e85" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b68">
	<analytic>
		<title level="a" type="main">The RUNX3 tumor suppressor upregulates Bim in gastric epithelial cells undergoing transforming growth factor beta-induced apoptosis</title>
		<author>
			<persName><forename type="first">T</forename><surname>Yano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Ito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Fukamachi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">Z</forename><surname>Chi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Wee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Inoue</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Cell Biol</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="4474" to="4e88" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b69">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">M</forename><surname>Yarmus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Woolf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Bernstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Fainaru</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Negreanu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Levanon</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b70">
	<analytic>
		<title level="a" type="main">Groucho/transducin-like Enhancer-of-split (TLE)-dependent and -independent transcriptional regulation by Runx3</title>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">103</biblScope>
			<biblScope unit="page" from="7384" to="e7389" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b71">
	<analytic>
		<title level="a" type="main">Molecular markers of early-stage mycosis fungoides</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Su</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Xiao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Invest Dermatol</title>
		<imprint>
			<biblScope unit="volume">132</biblScope>
			<biblScope unit="page" from="1698" to="e706" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
